The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for hypertension and heart failure
Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial
Martyn Thomas1*, MD; Christoph A. Nienaber2, MD; Hüseyin Ince2, MD, PhD; Andrejs Erglis3, MD, PhD; Vladan Vukcevic4, MD; Ulrich Schäfer5, MD; Rui Cruz Ferreira6, MD; Stefan Hardt7, MD; Stefan Verheye8, MD, PhD; Vasco Gama Ribeiro9, MD; Lissa Sugeng10, MD, MPH; Corrado Tamburino11, MD
1. St. Thomas’ Hospital, London, United Kingdom; 2. University of Rostock, Rostock, Germany; 3. Pauls Stradins Clinical University Hospital, Riga, Latvia; 4. Clinical Center of Serbia, Belgrade, Serbia; 5. Asklepios Klinik St. Georg, Hamburg, Germany; 6.
Aims: This prospective, non-randomised, observational study conducted in Europe was designed in order to assess the long-term safety and efficacy of the Parachute device in ischaemic hear